Voriconazole-induced periostitis in a patient with HIV treated for coccidioidomycosis meningitis.
Quynh P NguyenDarcy WootenPublished in: BMJ case reports (2024)
Voriconazole-induced periostitis is a rare adverse effect in patients on long-term therapy, characterised by periosteal inflammation and associated bony pain. The accompanying lab abnormalities (elevated serum alkaline phosphatase and fluoride) and characteristic imaging findings (uptake of radionuclide tracer on nuclear bone scan) are critical for diagnosis. The disease process is thought to be secondary to excess fluoride from voriconazole which stimulates bone formation and decreases osteoclast bone resorption. Management includes stopping voriconazole and switching to another agent.
Keyphrases
- bone loss
- end stage renal disease
- high glucose
- diabetic rats
- newly diagnosed
- oxidative stress
- drinking water
- bone mineral density
- ejection fraction
- chronic pain
- chronic kidney disease
- antiretroviral therapy
- hepatitis c virus
- hiv positive
- hiv infected
- computed tomography
- drug induced
- human immunodeficiency virus
- prognostic factors
- stem cells
- pain management
- magnetic resonance imaging
- soft tissue
- peritoneal dialysis
- case report
- hiv testing
- mesenchymal stem cells
- emergency department
- spinal cord
- endothelial cells
- men who have sex with men
- patient reported outcomes
- south africa
- positron emission tomography
- pet ct
- bone marrow
- pet imaging
- postmenopausal women
- stress induced
- replacement therapy